Pfizer Inc. and German partner BioNTech began testing their COVID-19 vaccine in children under 12 with hopes of expanding vaccination to that age range by early 2022, the U.S. drug maker said on Thursday.
Pfizer begins COVID-19 vaccine trial for children under 12
Post a Comment